POLBF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Jul 10 closing price
Capitalization
28.8M
SNSE
Price
$7.71
Change
-$0.13 (-1.66%)
Updated
Jul 21 closing price
Capitalization
9.72M
9 days until earnings call
Interact to see
Advertisement

POLBF vs SNSE

Header iconPOLBF vs SNSE Comparison
Open Charts POLBF vs SNSEBanner chart's image
Poolbeg Pharma
Price$0.04
Change-$0.00 (-0.00%)
Volume$50K
Capitalization28.8M
Sensei Biotherapeutics
Price$7.71
Change-$0.13 (-1.66%)
Volume$6.6K
Capitalization9.72M
POLBF vs SNSE Comparison Chart in %
Loading...
POLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
POLBF vs. SNSE commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is POLBF is a Buy and SNSE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (POLBF: $0.04 vs. SNSE: $7.71)
Brand notoriety: POLBF and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: POLBF: 107% vs. SNSE: 68%
Market capitalization -- POLBF: $28.8M vs. SNSE: $9.72M
POLBF [@Biotechnology] is valued at $28.8M. SNSE’s [@Biotechnology] market capitalization is $9.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

POLBF’s FA Score shows that 1 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • POLBF’s FA Score: 1 green, 4 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, both POLBF and SNSE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

POLBF’s TA Score shows that 0 TA indicator(s) are bullish while SNSE’s TA Score has 5 bullish TA indicator(s).

  • POLBF’s TA Score: 0 bullish, 2 bearish.
  • SNSE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SNSE is a better buy in the short-term than POLBF.

Price Growth

POLBF (@Biotechnology) experienced а 0.00% price change this week, while SNSE (@Biotechnology) price change was -4.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.39%. For the same industry, the average monthly price growth was +15.71%, and the average quarterly price growth was +33.77%.

Reported Earning Dates

SNSE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
POLBF($28.8M) has a higher market cap than SNSE($9.72M). SNSE YTD gains are higher at: -21.343 vs. POLBF (-63.983).
POLBFSNSEPOLBF / SNSE
Capitalization28.8M9.72M296%
EBITDAN/AN/A-
Gain YTD-63.983-21.343300%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/A3.21M-
TECHNICAL ANALYSIS
Technical Analysis
POLBFSNSE
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
20%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
10%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
10%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
N/A
Bullish Trend 20 days ago
74%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bearish Trend 4 days ago
9%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
POLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICAGY10.190.05
+0.54%
International Consolidated Airlines Group SA
VOPKY48.10N/A
N/A
Koninklijke Vopak NV
ZRSEF21.60N/A
N/A
DOCMORRIS AG
DBKSF1.00N/A
N/A
SPETZ INC.
BENZF0.37N/A
N/A
Benz Mining Corp

POLBF and

Correlation & Price change

A.I.dvisor tells us that POLBF and VSTM have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POLBF and VSTM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POLBF
1D Price
Change %
POLBF100%
N/A
VSTM - POLBF
29%
Poorly correlated
-1.16%
NNVC - POLBF
24%
Poorly correlated
+0.60%
SNSE - POLBF
24%
Poorly correlated
-1.66%
ALXO - POLBF
20%
Poorly correlated
-5.25%
OKYO - POLBF
12%
Poorly correlated
-5.69%
More

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with HURA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
-1.66%
HURA - SNSE
48%
Loosely correlated
-2.67%
VSTM - SNSE
46%
Loosely correlated
-1.16%
MOLN - SNSE
43%
Loosely correlated
+7.09%
GRI - SNSE
40%
Loosely correlated
+9.34%
INAB - SNSE
40%
Loosely correlated
+5.99%
More